contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-notice-of-extraordinary-general-meeting-1

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Aqua Bio Technology is a Norwegian company that operates in the cosmetics industry. The company develops, manufactures, and commercializes ingredients used in a number of cosmetic products worldwide. Their largest business consists of solutions for skincare products. Most of the company's products are sold worldwide via various distributors. Aqua Bio Technology was founded in 2004 and is headquartered in Lysaker.

Aqua Bio Technology

19.3.2025 11:41:42 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state An extraordinary general meeting of Aqua Bio Technology...

<pre>19.3.2025 11:41:42 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state An extraordinary general meeting of Aqua Bio Technology ASA (the "Company" or "ABTEC") will be held on 9 April 2025 at 10:00 (CET) at Advokatfirmaet CLP DA, Sommerrogata 13-15, 0255 Oslo. Please find attached the notice to the general meeting. All documents to be treated at the general meeting will be made available at the Company's website www.aquabiotechnology.com - http://www.aquabiotechnology.com - http://www.aquabiotechnology.com. Shareholders who wish to the attend the general meeting is requested to notify the Company as set out in Appendix 1 to the notice within 7 April 2025 at 16:00 (CET). In case of attendance by proxy, the proxy form (also included in appendix 1 to the notice) is requested submitted to be received by the Company within the same date. For further information, please contact Fredrik Henriksen, CEO Phone +47 900 20 078 Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective, and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. DISCLOSURE REGULATION This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act. CONTACTS * Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78, fredrik.henriksen@aquabiotech.no ABOUT AQUA BIO TECHNOLOGY ASA Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/18461728/5812/Download%20announce ment%20as%20PDF.pdf ABT - Innkalling EGF 09-04-25.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/18461728/5811/ABT%20-%20Innkallin g%20EGF%2009-04-25.pdf </pre>

Aqua Bio Technology: Notice of extraordinary general meeting

Return on capital (ROE, ROI, ROIC, RONIC)

Vad som står på spel för USA om exporten till Kina försvinner

U-sväng i tullcirkusen

Dollarns dominans – ohotad eller sårbar?  Om dollarns position som världsvaluta 

Potential for generous excess returns in Inderes recommendations